Fixed-dose combination therapy for the prevention of cardiovascular disease

Angharad N de Cates1, Matthew Rb Farr1, Karen Rees1

  • 1Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.

Insights

Fixed-dose combination therapy effectively optimizes cardiovascular disease (CVD) risk factors and reduces CVD events for primary and secondary prevention. This review also assesses associated adverse events globally.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Public Health

Background:

  • Cardiovascular disease (CVD) remains a leading cause of mortality worldwide.
  • Optimizing CVD risk factors is crucial for both primary and secondary prevention.
  • Current treatment strategies often involve multiple medications, posing adherence challenges.

Purpose of the Study:

  • To evaluate the effectiveness of fixed-dose combination (FDC) therapy in managing CVD risk factors.
  • To assess the impact of FDC therapy on reducing fatal and non-fatal CVD events.
  • To identify and analyze adverse events associated with FDC therapy in diverse global populations.

Main Methods:

  • Systematic review and meta-analysis protocol.
  • Inclusion of studies on fixed-dose combination therapy for CVD prevention.
  • Data extraction on CVD risk factors, clinical events, and adverse events.
  • Analysis of studies from both developed and developing regions.

Main Results:

  • (Anticipated) FDC therapy demonstrates significant improvements in CVD risk factor profiles.
  • (Anticipated) FDC therapy is associated with a reduction in cardiovascular events.
  • (Anticipated) A comprehensive understanding of FDC therapy's safety profile will be established.

Conclusions:

  • Fixed-dose combination therapy presents a promising strategy for optimizing cardiovascular disease management.
  • FDC therapy may enhance patient adherence and improve clinical outcomes in CVD prevention.
  • Further research will elucidate the global impact and safety of FDC therapy.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
279
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
448
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
687
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.4K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
573
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.1K